Northern Ireland has taken a decisive step by halting its participation in a contentious NHS England research program involving puberty blockers. The decision, driven by Health Minister Mike Nesbitt, comes amid ongoing legal disputes regarding the trial.
The suspended scheme involves administering puberty blockers to 226 children to study the drugs’ effects. Advocacy group ADF International has criticized the trial, labeling it as “reckless experimentation on children” with potential for “lifelong and often irreversible consequences.”
A judicial review is being sought by the Bayswater Support Group, psychotherapist James Esses, and detransitioner Keira Bell, who have filed a legal challenge in the High Court against the trial.
Initially, Nesbitt signaled Northern Ireland’s involvement in the trial but reversed his position shortly thereafter. He stated, “Should the trial ultimately be given the green light to proceed, I shall take the views of Executive colleagues before any potential lifting of the pause.”
The Christian Institute has expressed approval of Nesbitt’s decision to pause the trial. James Kennedy, the institute’s Northern Ireland policy officer, commented on the potential risks of the drugs.
“We are grateful that the Health Minister has put this cruel experiment on hold. While we don’t know of all the risks involved in puberty-blocking drugs, we do know they can cause irreversible harm,” said Kennedy.
He further explained that the drugs interfere with natural development, exacerbate anxiety, and hinder the natural resolution of gender distress. “Almost every child who takes these drugs progresses to taking cross-sex hormones, which have drastic lifelong impacts. It’s time for the Westminster Government to heed the growing disquiet over this unethical trial and ditch it altogether.”
The institute also referenced public opinion surveys showing 63 percent opposition to the trial, with particularly strong disapproval among parents of minors.
This article was originally written by www.christiantoday.com
